Cargando…

Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D

BACKGROUND: Management of diarrhoea-predominant irritable bowel syndrome (IBS-D) is generally based on patient-reported symptoms; however, limited information on symptom severity exists. The objective of the study was to assess the impact of IBS-D severity on patient burden and patient and healthcar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emmanuel, Anton, Goosey, Richard William, Wiseman, Gwen, Baker, Stephen, Törnblom, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183708/ https://www.ncbi.nlm.nih.gov/pubmed/32336287 http://dx.doi.org/10.1186/s12876-020-01252-9

Ejemplares similares

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences()
por: Kesuma, Yudianita, et al.
Publicado: (2019)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013)

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
por: Andrae, David A, et al.
Publicado: (2013)

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
por: Altomare, Annamaria, et al.
Publicado: (2021)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
por: Lin, Hao, et al.
Publicado: (2021)

The role of inflammation in irritable bowel syndrome (IBS)
por: Ng, Qin Xiang, et al.
Publicado: (2018)

Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS
por: Sarvepalli, Sai Suseel, et al.
Publicado: (2023)

Irritable bowel syndrome (IBS) among Lebanese adults: unidentified IBS and associated factors
por: Yazbeck, Gabriella, et al.
Publicado: (2023)

Episodic Memories Among Irritable Bowel Syndrome (IBS) Patients: An Important Aspect of the IBS Symptom Experience
por: Sayuk, Gregory S., et al.
Publicado: (2022)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)
por: Howell, Carol Angela, et al.
Publicado: (2022)

Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
por: Liu, Tong, et al.
Publicado: (2020)

Use of GELSECTAN(®) in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience
por: Bellini, Massimo, et al.
Publicado: (2021)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016)

Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
por: Russo, Francesco, et al.
Publicado: (2018)

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
por: Di Rosa, Claudia, et al.
Publicado: (2023)

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
por: Layer, Peter, et al.
Publicado: (2007)

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
por: Kemppinen, Anu, et al.
Publicado: (2020)

Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS)
por: Grinsvall, Cecilia, et al.
Publicado: (2021)

Development of an educational intervention for patients with Irritable Bowel Syndrome (IBS) – a pilot study
por: Ringström, Gisela, et al.
Publicado: (2009)

The Role of Positive Personality Traits in Emotion Regulation of Patients with Irritable Bowel Syndrome (IBS)
por: MAZAHERI, Mina, et al.
Publicado: (2015)

The use of RT-PCR for determination of separate end-points for the strains IB H120 and IB D274 in titration of the combination vaccine Poulvac IB(®) primer
por: Geerligs, H.J., et al.
Publicado: (2013)

Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner
por: Chen, Chunqiu, et al.
Publicado: (2015)

Electro-acupuncture decreases 5-HT, CGRP and increases NPY in the brain-gut axis in two rat models of Diarrhea-predominant irritable bowel syndrome(D-IBS)
por: Sun, Jianhua, et al.
Publicado: (2015)

Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H(2) or CH(4) production with severity of IBS
por: Onana Ndong, Philippe, et al.
Publicado: (2023)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

A Swedish national adoption study of risk of irritable bowel syndrome (IBS)
por: Waehrens, Rasmus, et al.
Publicado: (2017)

A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)
por: Ng, Qin Xiang, et al.
Publicado: (2018)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment
por: Dudzińska, Ewa, et al.
Publicado: (2023)

Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls
por: Nagel, Robyn, et al.
Publicado: (2015)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS)
por: Bengtsson, Mariette, et al.
Publicado: (2007)

Blastocystis sp. in Irritable Bowel Syndrome (IBS) - Detection in Stool Aspirates during Colonoscopy
por: Ragavan, Nanthiney Devi, et al.
Publicado: (2015)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)
por: Moayyedi, Paul, et al.
Publicado: (2019)

Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
por: Zhu, Lingping, et al.
Publicado: (2018)

Comparison between gluten-free regime and regime with gluten in symptoms of patients with irritable bowel syndrome (IBS)
por: Hajiani, Eskandar, et al.
Publicado: (2019)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76cvne8ap68iqscsffedepqfbd